ArticleReviews in cardiovascular medicine2025
Association Between Serum Lipid-Bilirubin Ratio and Clinical Prognosis Among Patients Undergoing Percutaneous Coronary Intervention After Coronary Artery Bypass Grafting.
Article in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The low-density lipoprotein cholesterol (LDL-C)/(high-density lipoprotein C (HDL-C) + direct bilirubin (DBIL)) ratio has been linked to the development of atherosclerosis. However, the association of this ratio with clinical outcomes in patients with prior coronary artery bypass grafting (CABG) undergoing percutaneous coronary intervention (PCI) remains unclear. Therefore, this study aimed to explore whether the LDL/(HDL + DBIL) ratio is predictive of clinical outcomes in this patient group. Methods: We retrospectively reviewed 1352 patients who underwent re-PCI after CABG surgery and categorized the patients into three groups based on the third quartile of the ratio levels. The primary endpoint was major adverse cardiovascular and cerebrovascular events (MACCE), defined as a composite of all-cause death, stroke, myocardial infarction, or target vessel revascularization. Results: During the follow-up period, the occurrence rate of MACCE in the high ratio group was significantly higher than that in the low to moderate ratio groups (9.9% vs. 11.4% vs. 20.1%; Conclusion: The LDL-C/(HDL-C + DBIL) ratio level is closely related to the risk of long-term MACCE in patients undergoing PCI after CABG surgery, and the LDL-C/(HDL-C + DBIL) level can be an important indicator for post-PCI risk assessment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.